What You Need To Know Ahead of Eli Lilly Earnings

Analyst Estimates for Q3 2024 Q2 2024 Q3 2023 Revenue $12.18 billion$11.3 billion $9.50 billion Earnings Per Share (Loss)$1.87 $3.28 (6 cents) Net Income (Loss)$1.69 billion $2.97 billion ($57.4 million) Key Metric: Research and Development Costs, Guidance Ahead of Wednesday's earnings announcement, Eli Lilly said it expects to report an IPR&D charge of about $2.83 billion for the quarter, well above the$154 million and $111 million, respectively, the company reported for the first two quarters of the y ...